{"id":47791,"date":"2022-08-30T12:02:25","date_gmt":"2022-08-30T10:02:25","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/"},"modified":"2022-08-30T12:02:25","modified_gmt":"2022-08-30T10:02:25","slug":"mannatech-declares-second-quarter-2022-dividend","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/","title":{"rendered":"Mannatech Declares Second Quarter 2022 Dividend"},"content":{"rendered":"
\n

FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated<\/a><\/i><\/b> (NASDAQ: MTEX<\/a>)<\/i>, a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 <\/sup>per share of common stock, payable on Wednesday, September 28, 2022, to shareholders of record at the close of business on Wednesday, September 14, 2022. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech\u2019s common stock.\n<\/p>\n

<\/a><\/p>\n

\nAlfredo \u201cAl\u201d Bala, President and CEO of Mannatech, said, \u201cMannatech is fully committed to delivering value to our shareholders.\u201d\n<\/p>\n

\nAbout Mannatech<\/b>\n<\/p>\n

\nMannatech, Incorporated is committed to transforming lives through the development of high quality integrated health, weight management, fitness and skin care products distributed through its global network of independent associates and members. The company has been operating for more than 25 years with operations in 25 markets^. For more information, visit Mannatech.com<\/a>.\n<\/p>\n

\n^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.\n<\/p>\n

\nPlease Note: This release contains \u201cforward-looking statements\u201d within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d “hope,” \u201ccould,\u201d \u201cwould,\u201d \u201cexpects,\u201d \u201cplans,\u201d \u201cintends,\u201d \u201canticipates,\u201d \u201cbelieves,\u201d \u201cestimates,\u201d \u201capproximates,\u201d \u201cpredicts,\u201d \u201cprojects,\u201d \u201cpotential,\u201d and \u201ccontinues\u201d or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech\u2019s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the outbreak of the novel coronavirus (“COVID-19”) pandemic, Mannatech\u2019s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDonna Giordano
\n
Manager, Executive Office Administration
\n
972-471-6512
\n
ir@mannatech.com<\/a>
www.mannatech.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 28, 2022, to shareholders of record at the close of business on … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47791","6":"format-standard","7":"category-industry"},"yoast_head":"\nMannatech Declares Second Quarter 2022 Dividend - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mannatech Declares Second Quarter 2022 Dividend - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 28, 2022, to shareholders of record at the close of business on ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-30T10:02:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Mannatech Declares Second Quarter 2022 Dividend\",\"datePublished\":\"2022-08-30T10:02:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/\"},\"wordCount\":451,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005748\\\/en\\\/579734\\\/21\\\/New_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/\",\"name\":\"Mannatech Declares Second Quarter 2022 Dividend - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005748\\\/en\\\/579734\\\/21\\\/New_Logo.jpg\",\"datePublished\":\"2022-08-30T10:02:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005748\\\/en\\\/579734\\\/21\\\/New_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005748\\\/en\\\/579734\\\/21\\\/New_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mannatech-declares-second-quarter-2022-dividend\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mannatech Declares Second Quarter 2022 Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mannatech Declares Second Quarter 2022 Dividend - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/","og_locale":"en_US","og_type":"article","og_title":"Mannatech Declares Second Quarter 2022 Dividend - Pharma Trend","og_description":"FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 28, 2022, to shareholders of record at the close of business on ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-30T10:02:25+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Mannatech Declares Second Quarter 2022 Dividend","datePublished":"2022-08-30T10:02:25+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/"},"wordCount":451,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/","url":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/","name":"Mannatech Declares Second Quarter 2022 Dividend - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg","datePublished":"2022-08-30T10:02:25+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005748\/en\/579734\/21\/New_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mannatech-declares-second-quarter-2022-dividend\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mannatech Declares Second Quarter 2022 Dividend"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47791"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47791\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}